Traws Pharma, Inc. (TRAW): Total Assets
$10.62M
As of 2025-12-31
$11.47M
As of 2026-06-30
-35.4%
3-year compound annual growth
-11.9%
5-year compound annual growth
-7.6%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.62M | -57.5% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $24.96M | +10.0% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $22.68M | -42.4% | 2025-03-31, Balance as of period end |
| 2022-12-31 | $39.37M | -29.0% | 2024-04-01, Balance as of period end |
| 2021-12-31 | $55.48M | +177.6% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $19.99M | -15.6% | 2022-03-21, Balance as of period end |
| 2019-12-31 | $23.67M | +32.1% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $17.92M | +260.0% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $4.98M | -78.6% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $23.23M | -0.9% | 2018-03-16, Balance as of period end |
| 2015-12-31 | $23.45M | -50.5% | 2017-03-29, Balance as of period end |
| 2014-12-31 | $47.34M | -55.0% | 2016-03-28, Balance as of period end |
| 2013-12-31 | $105.15M | +25.4% | 2015-03-30, Balance as of period end |
| 2012-12-31 | $83.85M | n/a | 2014-03-20, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $10.62M | -57.5% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $10.48M | +318.0% |
| Longeveron Inc. (LGVN) | 2025-12-31 | $10.26M | -59.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $11.04M | -56.8% |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $11.06M | +265.8% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $11.09M | +279.5% |
| Genprex, Inc. (GNPX) | 2025-12-31 | $10.16M | +146.3% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $11.12M | -31.6% |
| Oragenics Inc (OGEN) | 2025-12-31 | $10.07M | +583.7% |
Compare TRAW, SHPH, LGVN, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗